| Spirig HealthCare AG - Lacosamid Spirig HC 150 mg, Filmtabletten | | 70271 | | 03 | | Lacosamid Spirig HC 150 mg | | Filmtabletten | | N03AX18 | | Lacosamide | | 29.04.2026 | | |
| | Composition | | lacosamidum 150 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, crospovidonum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), E 132, pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | Principe actif | Concentr. |
|---|
| Lacosamidum | 150 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 132 | | color. | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hydroxypropylcellulosum Substitutum Humile | | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 005 | 14 | | | B | | Oui | | 006 | 56 | | | B | | Oui | | 007 | 168 | | | B | | Oui |
|
|
